The first new PTSD drug in over twenty years is up for approval. It will require U.S. regulators to do something they've never done before: greenlight the mind-altering and illegal party drug known as ecstasy.
Lykos Therapeutics Inc., advocates for bringing psychedelic therapy, proposes MDMA pill with 42 hours of talk therapy for PTSD patients.
The Department of Veterans Affairs considers psychedelics' significant potential for PTSD patients and prepares to provide the drug if approved.
[
add
]
[
|
|
...
]